Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Copper and antibiotics: discovery, modes of action, and opportunities for medicinal applications
AG Dalecki, CL Crawford, F Wolschendorf - Advances in microbial …, 2017 - Elsevier
Copper is a ubiquitous element in the environment as well as living organisms, with its redox
capabilities and complexation potential making it indispensable for many cellular functions …
capabilities and complexation potential making it indispensable for many cellular functions …
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Two parallel revolutions were born in the golden era of antibiotics (~ 1940 to 1960). One
was a revolution in medicine as physicians went to war with microbes. The second was a …
was a revolution in medicine as physicians went to war with microbes. The second was a …
Novel antimicrobial 8-hydroxyquinoline-based agents: Current development, structure–activity relationships, and perspectives
AR Joaquim, MP Gionbelli, G Gosmann… - Journal of Medicinal …, 2021 - ACS Publications
The search for new antimicrobials is imperative due to the emergent resistance of new
microorganism strains. In this context, revisiting known classes like 8-hydroxyquinolines …
microorganism strains. In this context, revisiting known classes like 8-hydroxyquinolines …
Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis
Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), a vital enzyme for cell wall
synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan. It …
synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan. It …
Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions
The genus Mycobacterium comprises a group of obligately aerobic bacteria that have
adapted to inhabit a wide range of intracellular and extracellular environments …
adapted to inhabit a wide range of intracellular and extracellular environments …
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for develo** novel drugs against TB
New classes of drugs are needed to treat tuberculosis (TB) in order to combat the
emergence of resistance (MDR and XDR) to existing agents and shorten the duration of …
emergence of resistance (MDR and XDR) to existing agents and shorten the duration of …
Novel targets in M. tuberculosis: search for new drugs
G Lamichhane - Trends in molecular medicine, 2011 - cell.com
The recent past has experienced a renaissance in tuberculosis (TB) research. New
molecular biology reagents and genetic tools have been developed and whole genome …
molecular biology reagents and genetic tools have been developed and whole genome …
Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase
M Krátký, J Vinšová, E Novotná, J Mandíková, V Wsól… - Tuberculosis, 2012 - Elsevier
The global burden of tuberculosis, its health and socio-economic impacts, the presence of
drug-resistant forms and a potential threat of latent tuberculosis should serve as a strong …
drug-resistant forms and a potential threat of latent tuberculosis should serve as a strong …
2, 4-Disubstituted thiazoles as multitargated bioactive molecules
Thiazoles are important heterocyclics exhibiting boundaryless biological activities, such as
antibacterial, antifungal, anti-inflammatory, antitumor, antitubercular, antidiabetic, antiviral …
antibacterial, antifungal, anti-inflammatory, antitumor, antitubercular, antidiabetic, antiviral …
Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)
A Egorova, EG Salina, V Makarov - International Journal of Molecular …, 2021 - mdpi.com
Latent tuberculosis infection (LTBI) represents a major challenge to curing TB disease.
Current guidelines for LTBI management include only three older drugs and their …
Current guidelines for LTBI management include only three older drugs and their …